Search details
1.
Tumor biomarkers and efficacy in patients treated with trastuzumab emtansine + pertuzumab versus standard of care in HER2-positive early breast cancer: an open-label, phase III study (KRISTINE).
Breast Cancer Res
; 25(1): 2, 2023 01 11.
Article
in English
| MEDLINE | ID: mdl-36631725
2.
ASTEFANIA: adjuvant ado-trastuzumab emtansine and atezolizumab for high-risk, HER2-positive breast cancer.
Future Oncol
; 18(32): 3563-3572, 2022 Oct.
Article
in English
| MEDLINE | ID: mdl-36382554
3.
Patient-reported outcomes from KATHERINE: A phase 3 study of adjuvant trastuzumab emtansine versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for human epidermal growth factor receptor 2-positive breast cancer.
Cancer
; 126(13): 3132-3139, 2020 07 01.
Article
in English
| MEDLINE | ID: mdl-32286687
4.
Biomarker Data from the Phase III KATHERINE Study of Adjuvant T-DM1 versus Trastuzumab for Residual Invasive Disease after Neoadjuvant Therapy for HER2-Positive Breast Cancer.
Clin Cancer Res
; 29(8): 1569-1581, 2023 04 14.
Article
in English
| MEDLINE | ID: mdl-36730339
5.
Adjuvant trastuzumab emtansine in HER2-positive breast cancer patients with HER2-negative residual invasive disease in KATHERINE.
NPJ Breast Cancer
; 8(1): 106, 2022 Sep 19.
Article
in English
| MEDLINE | ID: mdl-36117201
6.
Trastuzumab Emtansine Plus Pertuzumab Versus Taxane Plus Trastuzumab Plus Pertuzumab After Anthracycline for High-Risk Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: The Phase III KAITLIN Study.
J Clin Oncol
; 40(5): 438-448, 2022 02 10.
Article
in English
| MEDLINE | ID: mdl-34890214
7.
Impact on health-related quality of life of a switch from enfuvirtide to raltegravir among multidrug-resistant HIV-1-infected patients: a randomized open-label trial (EASIER-ANRS 138).
HIV Clin Trials
; 11(5): 283-93, 2010.
Article
in English
| MEDLINE | ID: mdl-21126958
8.
Genetic polymorphisms in 85 DNA repair genes and bladder cancer risk.
Carcinogenesis
; 30(5): 763-8, 2009 May.
Article
in English
| MEDLINE | ID: mdl-19237606
9.
CXCR4 expression in early breast cancer and risk of distant recurrence.
Oncologist
; 14(12): 1182-8, 2009 Dec.
Article
in English
| MEDLINE | ID: mdl-19939894
10.
Neoadjuvant Trastuzumab Emtansine and Pertuzumab in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Three-Year Outcomes From the Phase III KRISTINE Study.
J Clin Oncol
; 37(25): 2206-2216, 2019 09 01.
Article
in English
| MEDLINE | ID: mdl-31157583
11.
Variants in DNA double-strand break repair and DNA damage-response genes and susceptibility to lung and head and neck cancers.
Int J Cancer
; 123(2): 457-463, 2008 Jul 15.
Article
in English
| MEDLINE | ID: mdl-18449888
12.
Long-term in vivo imaging of viscoelastic properties of the mouse brain after controlled cortical impact.
J Neurotrauma
; 30(17): 1512-20, 2013 Sep 01.
Article
in English
| MEDLINE | ID: mdl-23534701
13.
Magnetic resonance elastography methodology for the evaluation of tissue engineered construct growth.
J Vis Exp
; (60)2012 Feb 09.
Article
in English
| MEDLINE | ID: mdl-22349156
14.
Microscopic magnetic resonance elastography of traumatic brain injury model.
J Neurosci Methods
; 201(2): 296-306, 2011 Oct 15.
Article
in English
| MEDLINE | ID: mdl-21871490
15.
Emerging integrase inhibitor resistance mutations in raltegravir-treated HIV-1-infected patients with low-level viremia.
AIDS
; 25(5): 665-9, 2011 Mar 13.
Article
in English
| MEDLINE | ID: mdl-21326075
16.
Neoadjuvant Trastuzumab Emtansine and Pertuzumab in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Three-Year Outcomes From the Phase III KRISTINE Study
J. Clin. Oncol
; 37(25): 2206-2216, setiembre, 2019. tab
Article
in English
| URUCAN | ID: bcc-5370
17.
Interleukin-2 before antiretroviral therapy in patients with HIV infection: a randomized trial (ANRS 119).
J Infect Dis
; 200(2): 206-15, 2009 Jul 15.
Article
in English
| MEDLINE | ID: mdl-19508157
18.
[Gene expression profiling in cancer research]. / Défis statistiques posés par les biopuces: autant d'espoir que de faux positifs?
Bull Cancer
; 94(11): 976-80, 2007 Nov.
Article
in French
| MEDLINE | ID: mdl-18055315
19.
Polymorphism discovery in 62 DNA repair genes and haplotype associations with risks for lung and head and neck cancers.
Carcinogenesis
; 28(8): 1731-9, 2007 Aug.
Article
in English
| MEDLINE | ID: mdl-17494052
Results
1 -
19
de 19
1
Next >
>>